Fresenius Kabi, an operating company of Fresenius, announced that Epinephrine Injection, USP, is now available in the U.S. in 30 mg per 30 mL multi-dose vials.

Epinephrine Injection in a 30 mg per 30 mL Multi-Dose Vial is now available from Fresenius Kabi, expanding the company’s offerings of Epinephrine Injection.

Epinephrine Injection in a 30 mg per 30 mL Multi-Dose Vial is now available from Fresenius Kabi, expanding the company’s offerings of Epinephrine Injection. In December 2024, Fresenius Kabi ...

Fresenius Kabi, an operating company of Fresenius, announced today that Epinephrine Injection, USP, is now available in the United States in 30 mg per 30 mL multi-dose vials.

The northward movement in the Biocon share price came following the news that the company's subsidiary has received approval from the US Food and Drug Administration (US FDA) for its ANDA ...

The FDA has approved neffy 1 mg epinephrine nasal spray for treating anaphylaxis and other type 1 allergic reactions in children aged 4 years and older, according to a press release from ARS ...

Glenmark's Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials can be expected to have the same therapeutic effect as the listed drug product upon which the Agency relied as the ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of epinephrine injection USP, 10 mg/10 mL (1 mg/mL) multiple-dose vial. Glenmark’s epinephrine injection USP, 10 mg/10 mL (1 mg/mL) ...

During EPINEPHrine shortage, 30 mL vials of topical EPINEPHrine were ordered by mistake and loaded into crash carts; the wrong product was reordered from the same order label several times ...

Glenmark Pharmaceuticals on Thursday launched of Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial. Epinephrine injection is used for emergency treatment of severe allergic ...

Glenmark Pharma announced that its US-based subsidiary, Glenmark Pharmaceuticals Inc, has launched the Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) multiple-dose vial.